Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Metabolism & Elimination The metabolic fate and degradation pathways of MOTS-c remain incompletely characterized, representing a significant gap in pharmacokinetic understanding: Rapid plasma clearance observed in preclinical models, though precise half-life not definitively established Likely degradation through peptidase activity, though specific enzymes not identified No accumulation detected in chronic administration studies (animal models) Active metabolites not characterized
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
Drugs like Wegovy and Ozempic are priced at about $1,000 per month without insurance coverage, while even patients with insurance are having trouble getting a prescription
Autoridade em Peptdeos
Most founders underestimate the cost of a compliance mistake, a single misconfigured integration can lead to liability, operational shutdown, or payer lockout
US$ 28.30
US$ 29.85
US$ 25.54
US$ 28.46
US$ 27.57
US$ 27.77
US$ 25.09
